Global Synthetic Lethality-based Drugs and Targets Market Insights and Forecast to 2031

Report ID: 1640813 | Published Date: Oct 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Medical Research Institution
        1.3.3 Hospital and Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2017-2028)
    2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Region
        2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Size by Region (2017-2022)
        2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2023-2028)
    2.3 Synthetic Lethality-based Drugs and Targets Market Dynamics
        2.3.1 Synthetic Lethality-based Drugs and Targets Industry Trends
        2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
        2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
        2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue
        3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2017-2022)
        3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2017-2022)
    3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
    3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
        3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2021
    3.5 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
    3.6 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
    3.7 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
    4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2017-2022)
    4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2023-2028)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
    5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2017-2022)
    5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2017-2028)
    6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
        6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022)
        6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028)
        6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
        6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022)
        6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028)
        6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
        6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022)
        6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2017-2028)
    7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
        7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022)
        7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028)
        7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
        7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022)
        7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028)
        7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
        7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022)
        7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size (2017-2028)
    8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type
        8.2.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application
        8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    8.4 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
        8.4.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size (2017-2028)
    9.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
        9.2.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022)
        9.2.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028)
        9.2.3 Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    9.3 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
        9.3.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022)
        9.3.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028)
        9.3.3 Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    9.4 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
        9.4.1 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022)
        9.4.2 Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size (2017-2028)
    10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type
        10.2.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application
        10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    10.4 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
        10.4.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
        11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.1.5 AbbVie Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
        11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.2.5 AstraZeneca Recent Developments
    11.3 BeiGene
        11.3.1 BeiGene Company Details
        11.3.2 BeiGene Business Overview
        11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
        11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.3.5 BeiGene Recent Developments
    11.4 Clovis Oncology
        11.4.1 Clovis Oncology Company Details
        11.4.2 Clovis Oncology Business Overview
        11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
        11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.4.5 Clovis Oncology Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
        11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
        11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.6.5 Pfizer Recent Developments
    11.7 AtlasMedx
        11.7.1 AtlasMedx Company Details
        11.7.2 AtlasMedx Business Overview
        11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
        11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.7.5 AtlasMedx Recent Developments
    11.8 Chordia Therapeutics
        11.8.1 Chordia Therapeutics Company Details
        11.8.2 Chordia Therapeutics Business Overview
        11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.8.5 Chordia Therapeutics Recent Developments
    11.9 IDEAYA Biosciences
        11.9.1 IDEAYA Biosciences Company Details
        11.9.2 IDEAYA Biosciences Business Overview
        11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
        11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.9.5 IDEAYA Biosciences Recent Developments
    11.10 Mission Therapeutics
        11.10.1 Mission Therapeutics Company Details
        11.10.2 Mission Therapeutics Business Overview
        11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.10.5 Mission Therapeutics Recent Developments
    11.11 Repare Therapeutics
        11.11.1 Repare Therapeutics Company Details
        11.11.2 Repare Therapeutics Business Overview
        11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
        11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.11.5 Repare Therapeutics Recent Developments
    11.12 Sierra Oncology
        11.12.1 Sierra Oncology Company Details
        11.12.2 Sierra Oncology Business Overview
        11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
        11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.12.5 Sierra Oncology Recent Developments
    11.13 SyntheX Labs
        11.13.1 SyntheX Labs Company Details
        11.13.2 SyntheX Labs Business Overview
        11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
        11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
        11.13.5 SyntheX Labs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2017-2022)
    Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2023-2028)
    Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
    Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
    Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
    Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
    Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players (2017-2022)
    Table 16. Global Top Synthetic Lethality-based Drugs and Targets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2021)
    Table 17. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
    Table 21. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2017-2022)
    Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2023-2028)
    Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2017-2022)
    Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2023-2028)
    Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size by Country (2023-2028) & (US$ Million)
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Synthetic Lethality-based Drugs and Targets Product
    Table 64. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 65. AbbVie Recent Developments
    Table 66. AstraZeneca Company Details
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
    Table 69. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 70. AstraZeneca Recent Developments
    Table 71. BeiGene Company Details
    Table 72. BeiGene Business Overview
    Table 73. BeiGene Synthetic Lethality-based Drugs and Targets Product
    Table 74. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 75. BeiGene Recent Developments
    Table 76. Clovis Oncology Company Details
    Table 77. Clovis Oncology Business Overview
    Table 78. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 79. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 80. Clovis Oncology Recent Developments
    Table 81. GlaxoSmithKline Company Details
    Table 82. GlaxoSmithKline Business Overview
    Table 83. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
    Table 84. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 85. GlaxoSmithKline Recent Developments
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Synthetic Lethality-based Drugs and Targets Product
    Table 89. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 90. Pfizer Recent Developments
    Table 91. AtlasMedx Company Details
    Table 92. AtlasMedx Business Overview
    Table 93. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
    Table 94. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 95. AtlasMedx Recent Developments
    Table 96. Chordia Therapeutics Company Details
    Table 97. Chordia Therapeutics Business Overview
    Table 98. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 99. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 100. Chordia Therapeutics Recent Developments
    Table 101. IDEAYA Biosciences Company Details
    Table 102. IDEAYA Biosciences Business Overview
    Table 103. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
    Table 104. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 105. IDEAYA Biosciences Recent Developments
    Table 106. Mission Therapeutics Company Details
    Table 107. Mission Therapeutics Business Overview
    Table 108. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 109. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 110. Mission Therapeutics Recent Developments
    Table 111. Repare Therapeutics Company Details
    Table 112. Repare Therapeutics Business Overview
    Table 113. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 114. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 115. Repare Therapeutics Recent Developments
    Table 116. Sierra Oncology Company Details
    Table 117. Sierra Oncology Business Overview
    Table 118. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 119. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 120. Sierra Oncology Recent Developments
    Table 121. SyntheX Labs Company Details
    Table 122. SyntheX Labs Business Overview
    Table 123. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
    Table 124. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 125. SyntheX Labs Recent Developments
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2021 VS 2028
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2021 VS 2028
    Figure 5. Medical Research Institution Case Studies
    Figure 6. Hospital and Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
    Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Region: 2021 VS 2028
    Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2021
    Figure 13. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2021
    Figure 15. North America Synthetic Lethality-based Drugs and Targets Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Synthetic Lethality-based Drugs and Targets Market Size Market Share by Type (2017-2028)
    Figure 17. North America Synthetic Lethality-based Drugs and Targets Market Size Market Share by Application (2017-2028)
    Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Size Share by Country (2017-2028)
    Figure 19. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Synthetic Lethality-based Drugs and Targets Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Synthetic Lethality-based Drugs and Targets Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Size Share by Country (2017-2028)
    Figure 25. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Synthetic Lethality-based Drugs and Targets Market Size Share by Region (2017-2028)
    Figure 35. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Synthetic Lethality-based Drugs and Targets Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Synthetic Lethality-based Drugs and Targets Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Synthetic Lethality-based Drugs and Targets Market Size Share by Country (2017-2028)
    Figure 45. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size Share by Country (2017-2028)
    Figure 51. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 55. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 56. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 57. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 60. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 61. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 62. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 63. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 64. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 65. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 66. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
AstraZeneca
BeiGene
Clovis Oncology
GlaxoSmithKline
Pfizer
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
Frequently Asked Questions
Synthetic Lethality-based Drugs and Targets report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Synthetic Lethality-based Drugs and Targets report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Synthetic Lethality-based Drugs and Targets report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports